表紙
市場調查報告書

全球免疫螢光試驗市場

Immunofluorescence Assays

出版商 Global Industry Analysts, Inc. 商品編碼 907347
出版日期 內容資訊 英文 285 Pages
商品交期: 最快1-2個工作天內
價格
全球免疫螢光試驗市場 Immunofluorescence Assays
出版日期: 2020年09月01日內容資訊: 英文 285 Pages
簡介

本報告提供全球免疫螢光試驗市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 全球市場佔有率方案
    • 各分類市場佔有率
    • 試劑
    • 計量儀器
    • 抗體
    • 套件
    • 消耗品·配件
    • 間接性免疫螢光
    • 直接性免疫螢光
  • 關注企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 亞太地區
  • 其他各國

第4章 競爭

  • ABCAM PLC
  • BIO-RAD LABORATORIES
  • CELL SIGNALING TECHNOLOGY
  • DANAHER CORPORATION
  • INOVA DIAGNOSTICS
  • MEDIPAN GMBH
  • MILLIPORESIGMA
  • PERKINELMER
  • SINO BIOLOGICAL
  • THERMO FISHER SCIENTIFIC
  • VECTOR LABORATORIES, INC.

第5章 相關調查

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP12534

Global Immunofluorescence Assays Market to Reach $2.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Immunofluorescence Assays estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 5% CAGR and reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $481 Million, While China is Forecast to Grow at 4.1% CAGR

The Immunofluorescence Assays market in the U.S. is estimated at US$481 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$390.3 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Antibodies Segment to Record 3.8% CAGR

In the global Antibodies segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$149 Million in the year 2020 will reach a projected size of US$193.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$252.7 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 285-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • INOVA Diagnostics, Inc.
  • Medipan GmbH
  • MilliporeSigma
  • PerkinElmer, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Immunofluorescence Assay Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Immunofluorescence Assays Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020
    • TABLE 2: Immunofluorescence Assays Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012
    • TABLE 3: Immunofluorescence Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Reagents (Product) World Market by Region/Country in US$ Thousand: 2020 to
    • TABLE 5: Reagents (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to
    • TABLE 6: Reagents (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Instruments (Product) Potential Growth Markets Worldwide in US$ Thousand: 2020 to
    • TABLE 8: Instruments (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to
    • TABLE 9: Instruments (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Antibodies (Product) Geographic Market Spread Worldwide in US$ Thousand: 2020 to
    • TABLE 11: Antibodies (Product) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to
    • TABLE 12: Antibodies (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Kits (Product) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to
    • TABLE 14: Kits (Product) Market Historic Review by Region/Country in US$ Thousand: 2012 to
    • TABLE 15: Kits (Product) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Consumables & Accessories (Product) World Market by Region/Country in US$ Thousand: 2020 to
    • TABLE 17: Consumables & Accessories (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to
    • TABLE 18: Consumables & Accessories (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 19: Indirect Immunofluorescence (Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to
    • TABLE 20: Indirect Immunofluorescence (Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2012 to
    • TABLE 21: Indirect Immunofluorescence (Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 22: Direct Immunofluorescence (Type) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to
    • TABLE 23: Direct Immunofluorescence (Type) Global Historic Demand in US$ Thousand by Region/Country: 2012 to
    • TABLE 24: Direct Immunofluorescence (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 25: Cancer (Disease) World Market by Region/Country in US$ Thousand: 2020 to
    • TABLE 26: Cancer (Disease) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to
    • TABLE 27: Cancer (Disease) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 28: Infectious Diseases (Disease) Potential Growth Markets Worldwide in US$ Thousand: 2020 to
    • TABLE 29: Infectious Diseases (Disease) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to
    • TABLE 30: Infectious Diseases (Disease) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 31: Autoimmune Diseases (Disease) Geographic Market Spread Worldwide in US$ Thousand: 2020 to
    • TABLE 32: Autoimmune Diseases (Disease) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to
    • TABLE 33: Autoimmune Diseases (Disease) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 34: Cardiovascular Diseases (Disease) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to
    • TABLE 35: Cardiovascular Diseases (Disease) Market Historic Review by Region/Country in US$ Thousand: 2012 to
    • TABLE 36: Cardiovascular Diseases (Disease) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 37: Other Diseases (Disease) World Market by Region/Country in US$ Thousand: 2020 to
    • TABLE 38: Other Diseases (Disease) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to
    • TABLE 39: Other Diseases (Disease) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 40: Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020
    • TABLE 41: Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012
    • TABLE 42: Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 43: Academic & Research Institutes (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020
    • TABLE 44: Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2012
    • TABLE 45: Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS
    • TABLE 46: Hospitals & Diagnostic Centers (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020
    • TABLE 47: Hospitals & Diagnostic Centers (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012
    • TABLE 48: Hospitals & Diagnostic Centers (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 49: Contract Research Organizations (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020
    • TABLE 50: Contract Research Organizations (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012
    • TABLE 51: Contract Research Organizations (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Immunofluorescence Assay Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 52: United States Immunofluorescence Assays Market Estimates and Projections in US$ Thousand by Product: 2020 to
    • TABLE 53: Immunofluorescence Assays Market in the United States by Product: A Historic Review in US$ Thousand for 2012
    • TABLE 54: United States Immunofluorescence Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 55: United States Immunofluorescence Assays Market Estimates and Projections in US$ Thousand by Type: 2020 to
    • TABLE 56: Immunofluorescence Assays Market in the United States by Type: A Historic Review in US$ Thousand for 2012
    • TABLE 57: United States Immunofluorescence Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 58: United States Immunofluorescence Assays Market Estimates and Projections in US$ Thousand by Disease: 2020 to
    • TABLE 59: Immunofluorescence Assays Market in the United States by Disease: A Historic Review in US$ Thousand for 2012
    • TABLE 60: United States Immunofluorescence Assays Market Share Breakdown by Disease: 2012 VS 2020 VS
    • TABLE 61: United States Immunofluorescence Assays Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to
    • TABLE 62: Immunofluorescence Assays Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012
    • TABLE 63: Immunofluorescence Assays Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS
  • CANADA
    • TABLE 64: Canadian Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020 to
    • TABLE 65: Canadian Immunofluorescence Assays Historic Market Review by Product in US$ Thousand: 2012
    • TABLE 66: Immunofluorescence Assays Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and
    • TABLE 67: Canadian Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Type: 2020 to
    • TABLE 68: Canadian Immunofluorescence Assays Historic Market Review by Type in US$ Thousand: 2012
    • TABLE 69: Immunofluorescence Assays Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and
    • TABLE 70: Canadian Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Disease: 2020 to
    • TABLE 71: Canadian Immunofluorescence Assays Historic Market Review by Disease in US$ Thousand: 2012
    • TABLE 72: Immunofluorescence Assays Market in Canada: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and
    • TABLE 73: Canadian Immunofluorescence Assays Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to
    • TABLE 74: Immunofluorescence Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012
    • TABLE 75: Canadian Immunofluorescence Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • JAPAN
    • TABLE 76: Japanese Market for Immunofluorescence Assays: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2020
    • TABLE 77: Immunofluorescence Assays Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2012
    • TABLE 78: Japanese Immunofluorescence Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 79: Japanese Market for Immunofluorescence Assays: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020
    • TABLE 80: Immunofluorescence Assays Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012
    • TABLE 81: Japanese Immunofluorescence Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 82: Japanese Market for Immunofluorescence Assays: Annual Sales Estimates and Projections in US$ Thousand by Disease for the Period 2020
    • TABLE 83: Immunofluorescence Assays Market in Japan: Historic Sales Analysis in US$ Thousand by Disease for the Period 2012
    • TABLE 84: Japanese Immunofluorescence Assays Market Share Analysis by Disease: 2012 VS 2020 VS
    • TABLE 85: Japanese Demand Estimates and Forecasts for Immunofluorescence Assays in US$ Thousand by End-Use: 2020 to
    • TABLE 86: Japanese Immunofluorescence Assays Market in US$ Thousand by End-Use: 2012
    • TABLE 87: Immunofluorescence Assays Market Share Shift in Japan by End-Use: 2012 VS 2020 VS
  • CHINA
    • TABLE 88: Chinese Immunofluorescence Assays Market Growth Prospects in US$ Thousand by Product for the Period 2020
    • TABLE 89: Immunofluorescence Assays Historic Market Analysis in China in US$ Thousand by Product: 2012
    • TABLE 90: Chinese Immunofluorescence Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 91: Chinese Immunofluorescence Assays Market Growth Prospects in US$ Thousand by Type for the Period 2020
    • TABLE 92: Immunofluorescence Assays Historic Market Analysis in China in US$ Thousand by Type: 2012
    • TABLE 93: Chinese Immunofluorescence Assays Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 94: Chinese Immunofluorescence Assays Market Growth Prospects in US$ Thousand by Disease for the Period 2020
    • TABLE 95: Immunofluorescence Assays Historic Market Analysis in China in US$ Thousand by Disease: 2012
    • TABLE 96: Chinese Immunofluorescence Assays Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 97: Chinese Demand for Immunofluorescence Assays in US$ Thousand by End-Use: 2020 to
    • TABLE 98: Immunofluorescence Assays Market Review in China in US$ Thousand by End-Use: 2012
    • TABLE 99: Chinese Immunofluorescence Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Immunofluorescence Assay Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 100: European Immunofluorescence Assays Market Demand Scenario in US$ Thousand by Region/Country: 2020
    • TABLE 101: Immunofluorescence Assays Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012
    • TABLE 102: European Immunofluorescence Assays Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 103: European Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020
    • TABLE 104: Immunofluorescence Assays Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2012
    • TABLE 105: European Immunofluorescence Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 106: European Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Type: 2020
    • TABLE 107: Immunofluorescence Assays Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012
    • TABLE 108: European Immunofluorescence Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 109: European Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Disease: 2020
    • TABLE 110: Immunofluorescence Assays Market in Europe in US$ Thousand by Disease: A Historic Review for the Period 2012
    • TABLE 111: European Immunofluorescence Assays Market Share Breakdown by Disease: 2012 VS 2020 VS
    • TABLE 112: European Immunofluorescence Assays Addressable Market Opportunity in US$ Thousand by End-Use: 2020
    • TABLE 113: Immunofluorescence Assays Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012
    • TABLE 114: European Immunofluorescence Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • FRANCE
    • TABLE 115: Immunofluorescence Assays Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 116: French Immunofluorescence Assays Historic Market Scenario in US$ Thousand by Product: 2012
    • TABLE 117: French Immunofluorescence Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 118: Immunofluorescence Assays Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 119: French Immunofluorescence Assays Historic Market Scenario in US$ Thousand by Type: 2012
    • TABLE 120: French Immunofluorescence Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 121: Immunofluorescence Assays Market in France by Disease: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 122: French Immunofluorescence Assays Historic Market Scenario in US$ Thousand by Disease: 2012
    • TABLE 123: French Immunofluorescence Assays Market Share Analysis by Disease: 2012 VS 2020 VS
    • TABLE 124: Immunofluorescence Assays Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020
    • TABLE 125: French Immunofluorescence Assays Historic Market Review in US$ Thousand by End-Use: 2012
    • TABLE 126: French Immunofluorescence Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • GERMANY
    • TABLE 127: Immunofluorescence Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2020
    • TABLE 128: German Immunofluorescence Assays Historic Market Analysis in US$ Thousand by Product: 2012
    • TABLE 129: German Immunofluorescence Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 130: Immunofluorescence Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020
    • TABLE 131: German Immunofluorescence Assays Historic Market Analysis in US$ Thousand by Type: 2012
    • TABLE 132: German Immunofluorescence Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 133: Immunofluorescence Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease for the Period 2020
    • TABLE 134: German Immunofluorescence Assays Historic Market Analysis in US$ Thousand by Disease: 2012
    • TABLE 135: German Immunofluorescence Assays Market Share Breakdown by Disease: 2012 VS 2020 VS
    • TABLE 136: Immunofluorescence Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020
    • TABLE 137: German Immunofluorescence Assays Market in Retrospect in US$ Thousand by End-Use: 2012
    • TABLE 138: Immunofluorescence Assays Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS
  • ITALY
    • TABLE 139: Italian Immunofluorescence Assays Market Growth Prospects in US$ Thousand by Product for the Period 2020
    • TABLE 140: Immunofluorescence Assays Historic Market Analysis in Italy in US$ Thousand by Product: 2012
    • TABLE 141: Italian Immunofluorescence Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 142: Italian Immunofluorescence Assays Market Growth Prospects in US$ Thousand by Type for the Period 2020
    • TABLE 143: Immunofluorescence Assays Historic Market Analysis in Italy in US$ Thousand by Type: 2012
    • TABLE 144: Italian Immunofluorescence Assays Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 145: Italian Immunofluorescence Assays Market Growth Prospects in US$ Thousand by Disease for the Period 2020
    • TABLE 146: Immunofluorescence Assays Historic Market Analysis in Italy in US$ Thousand by Disease: 2012
    • TABLE 147: Italian Immunofluorescence Assays Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 148: Italian Demand for Immunofluorescence Assays in US$ Thousand by End-Use: 2020 to
    • TABLE 149: Immunofluorescence Assays Market Review in Italy in US$ Thousand by End-Use: 2012
    • TABLE 150: Italian Immunofluorescence Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 151: United Kingdom Market for Immunofluorescence Assays: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2020
    • TABLE 152: Immunofluorescence Assays Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2012
    • TABLE 153: United Kingdom Immunofluorescence Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 154: United Kingdom Market for Immunofluorescence Assays: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020
    • TABLE 155: Immunofluorescence Assays Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012
    • TABLE 156: United Kingdom Immunofluorescence Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 157: United Kingdom Market for Immunofluorescence Assays: Annual Sales Estimates and Projections in US$ Thousand by Disease for the Period 2020
    • TABLE 158: Immunofluorescence Assays Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease for the Period 2012
    • TABLE 159: United Kingdom Immunofluorescence Assays Market Share Analysis by Disease: 2012 VS 2020 VS
    • TABLE 160: United Kingdom Demand Estimates and Forecasts for Immunofluorescence Assays in US$ Thousand by End-Use: 2020 to
    • TABLE 161: United Kingdom Immunofluorescence Assays Market in US$ Thousand by End-Use: 2012
    • TABLE 162: Immunofluorescence Assays Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 163: Rest of Europe Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020
    • TABLE 164: Immunofluorescence Assays Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2012
    • TABLE 165: Rest of Europe Immunofluorescence Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 166: Rest of Europe Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Type: 2020
    • TABLE 167: Immunofluorescence Assays Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012
    • TABLE 168: Rest of Europe Immunofluorescence Assays Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 169: Rest of Europe Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Disease: 2020
    • TABLE 170: Immunofluorescence Assays Market in Rest of Europe in US$ Thousand by Disease: A Historic Review for the Period 2012
    • TABLE 171: Rest of Europe Immunofluorescence Assays Market Share Breakdown by Disease: 2012 VS 2020 VS
    • TABLE 172: Rest of Europe Immunofluorescence Assays Addressable Market Opportunity in US$ Thousand by End-Use: 2020
    • TABLE 173: Immunofluorescence Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012
    • TABLE 174: Rest of Europe Immunofluorescence Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 175: Immunofluorescence Assays Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 176: Asia-Pacific Immunofluorescence Assays Historic Market Scenario in US$ Thousand by Product: 2012
    • TABLE 177: Asia-Pacific Immunofluorescence Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 178: Immunofluorescence Assays Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 179: Asia-Pacific Immunofluorescence Assays Historic Market Scenario in US$ Thousand by Type: 2012
    • TABLE 180: Asia-Pacific Immunofluorescence Assays Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 181: Immunofluorescence Assays Market in Asia-Pacific by Disease: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 182: Asia-Pacific Immunofluorescence Assays Historic Market Scenario in US$ Thousand by Disease: 2012
    • TABLE 183: Asia-Pacific Immunofluorescence Assays Market Share Analysis by Disease: 2012 VS 2020 VS
    • TABLE 184: Immunofluorescence Assays Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020
    • TABLE 185: Asia-Pacific Immunofluorescence Assays Historic Market Review in US$ Thousand by End-Use: 2012
    • TABLE 186: Asia-Pacific Immunofluorescence Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • REST OF WORLD
    • TABLE 187: Rest of World Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020 to
    • TABLE 188: Rest of World Immunofluorescence Assays Historic Market Review by Product in US$ Thousand: 2012
    • TABLE 189: Immunofluorescence Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and
    • TABLE 190: Rest of World Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Type: 2020 to
    • TABLE 191: Rest of World Immunofluorescence Assays Historic Market Review by Type in US$ Thousand: 2012
    • TABLE 192: Immunofluorescence Assays Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2012, 2020, and
    • TABLE 193: Rest of World Immunofluorescence Assays Market Estimates and Forecasts in US$ Thousand by Disease: 2020 to
    • TABLE 194: Rest of World Immunofluorescence Assays Historic Market Review by Disease in US$ Thousand: 2012
    • TABLE 195: Immunofluorescence Assays Market in Rest of World: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and
    • TABLE 196: Rest of World Immunofluorescence Assays Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to
    • TABLE 197: Immunofluorescence Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012
    • TABLE 198: Rest of World Immunofluorescence Assays Market Share Analysis by End-Use: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 42